[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1214523A1 - 醋酸格拉替雷的透粘膜給藥 - Google Patents

醋酸格拉替雷的透粘膜給藥

Info

Publication number
HK1214523A1
HK1214523A1 HK16102544.9A HK16102544A HK1214523A1 HK 1214523 A1 HK1214523 A1 HK 1214523A1 HK 16102544 A HK16102544 A HK 16102544A HK 1214523 A1 HK1214523 A1 HK 1214523A1
Authority
HK
Hong Kong
Prior art keywords
glatiramer acetate
transmucosal delivery
transmucosal
delivery
glatiramer
Prior art date
Application number
HK16102544.9A
Other languages
English (en)
Inventor
Geister Ursula
Schweizer Stephan
Buerger Martina
Stefan Ralph
Huber Gerald
Pries Tanja
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of HK1214523A1 publication Critical patent/HK1214523A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16102544.9A 2012-12-21 2016-03-07 醋酸格拉替雷的透粘膜給藥 HK1214523A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261745226P 2012-12-21 2012-12-21
PCT/US2013/077034 WO2014100639A1 (en) 2012-12-21 2013-12-20 Transmucosal delivery of glatiramer acetate

Publications (1)

Publication Number Publication Date
HK1214523A1 true HK1214523A1 (zh) 2016-07-29

Family

ID=50979257

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16102020.2A HK1214134A1 (zh) 2012-12-21 2016-02-23 醋酸格拉替雷的透粘膜給藥
HK16102544.9A HK1214523A1 (zh) 2012-12-21 2016-03-07 醋酸格拉替雷的透粘膜給藥

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK16102020.2A HK1214134A1 (zh) 2012-12-21 2016-02-23 醋酸格拉替雷的透粘膜給藥

Country Status (15)

Country Link
US (1) US20160193276A1 (zh)
EP (1) EP2934492A4 (zh)
JP (1) JP2016503803A (zh)
KR (1) KR20150111918A (zh)
CN (1) CN104869983A (zh)
AU (1) AU2013361053A1 (zh)
BR (1) BR112015014095A2 (zh)
CA (1) CA2895359A1 (zh)
EA (1) EA201591188A1 (zh)
HK (2) HK1214134A1 (zh)
IL (1) IL239280A0 (zh)
MX (1) MX2015007678A (zh)
SG (1) SG11201504422XA (zh)
WO (1) WO2014100639A1 (zh)
ZA (1) ZA201505049B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2627669T (pt) 2010-10-11 2016-11-24 Teva Pharma Biomarcadores de citocina como biomarcadores preditivos de resposta clínica para acetato de glatirâmero
US8815511B2 (en) 2011-10-10 2014-08-26 Teva Pharmaceutical Industries, Ltd. Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate
UY35790A (es) 2013-10-21 2015-05-29 Teva Pharma Marcadores genéticos que predicen la respuesta al acetato de glatiramer
US10493122B2 (en) 2014-03-17 2019-12-03 Mapi Pharma Ltd. Sublingual delivery of glatiramer acetate
CN106924175B (zh) * 2015-12-29 2020-07-03 深圳翰宇药业股份有限公司 一种治疗多发性硬化症的药物组合物
WO2017138645A1 (ja) * 2016-02-12 2017-08-17 テイカ製薬株式会社 乾式造粒物及び該乾式造粒物を含有する固形製剤並びにそれらの製造方法
CA3067681A1 (en) 2017-06-26 2019-01-03 Institut Pasteur Treatments to eliminate hiv reservoirs and reduce viral load

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200206457B (en) * 2000-02-18 2003-08-13 Yeda Res & Dev Oral, nasal and pulmonary dosage formulations of copolymer 1.
MXPA02008023A (es) * 2000-02-18 2005-06-30 Yeda Res & Dev Formulaciones de copolimero 1 para dosificacion oral, nasal y pulmonar.
KR100892333B1 (ko) * 2001-07-10 2009-04-08 테바 파마슈티컬 인더스트리즈 리미티드 0차, 0차-2상, 증가적 또는 감소적 약물 전달을 위한 약물전달 시스템
CA2596664A1 (en) * 2005-02-17 2006-08-24 Teva Pharmaceutical Industries Ltd. Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
JP2009515956A (ja) * 2005-11-22 2009-04-16 テバ ファーマシューティカル インダストリーズ リミティド テルミサルタンの医薬組成物
BRPI0620578A2 (pt) * 2005-12-27 2011-12-06 Jubilant Organosys Ltd composição farmacêutica que dissolve na boca e processo para o preparo da mesma
LT2529622T (lt) * 2006-09-22 2018-05-10 Pharmacyclics Llc Brutono tirozinkinazės inhibitoriai
ES2329327B1 (es) * 2008-03-19 2010-09-17 Proyecto De Biomedicina Cima, S.L. Combinaciones sinergicas de 5'-metiltioadenosina.

Also Published As

Publication number Publication date
ZA201505049B (en) 2016-10-26
HK1214134A1 (zh) 2016-07-22
BR112015014095A2 (pt) 2017-07-11
US20160193276A1 (en) 2016-07-07
SG11201504422XA (en) 2015-07-30
AU2013361053A1 (en) 2015-07-30
MX2015007678A (es) 2015-09-07
CN104869983A (zh) 2015-08-26
EA201591188A1 (ru) 2016-04-29
EP2934492A1 (en) 2015-10-28
CA2895359A1 (en) 2014-06-26
JP2016503803A (ja) 2016-02-08
KR20150111918A (ko) 2015-10-06
EP2934492A4 (en) 2016-08-17
WO2014100639A1 (en) 2014-06-26
IL239280A0 (en) 2015-07-30

Similar Documents

Publication Publication Date Title
HK1215817A1 (zh) 內容遞送框架
ZA201502352B (en) Liposomal drug delivery system
EP2683431A4 (en) DRUG DELIVERY SYSTEM
IL236268B (en) Preparations for mucosal administration and their uses
HK1208155A1 (zh) 工程多肽的經粘膜遞送
EP2836982A4 (en) DIGITAL CONTENT DELIVERANCE
HK1214523A1 (zh) 醋酸格拉替雷的透粘膜給藥
HK1207295A1 (zh) 生育三烯酚的經粘膜遞送
HK1202826A1 (zh) 藥物輸送裝置
GB201213491D0 (en) Content delivery system
HK1215529A1 (zh) 口腔經粘膜藥物遞送系統
AU2013344654A1 (en) Oral transmucosal drug delivery system
IL229425A0 (en) Controlled release drug administration preparations
HK1202827A1 (zh) 改進型藥物輸送裝置
HK1214522A1 (zh) 醋酸格拉默的口腔透黏膜給藥
EP2926712A4 (en) GAS RELEASE SYSTEM
HK1215668A1 (zh) 醋酸卡泊芬淨製劑
SG10201609440WA (en) Multi-additive delivery system
PL2908837T3 (pl) Kompozycje do dostarczania leku
SG11201405743QA (en) Liposomal delivery system
GB201121693D0 (en) Medicament delivery technology